sulbactam has been researched along with Pneumonia, Pneumococcal in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Fujii, K; Hishiki, H; Hotta, M; Ishiwada, N; Murata, S; Ohkusu, M; Takeuchi, N | 1 |
Chang, B; Fujiwara, N; Goto, N; Hama, M; Iwanami, N; Sekiguchi, M; Takahashi, Y; Yamazaki, M; Yamazaki, Y | 1 |
Drewelow, B; Frimmel, S; Klammt, S; Loebermann, M; Majcher-Peszynska, J; Mundkowski, RG; Reisinger, EC; Welte, T | 1 |
Arbo, A; Lovera, D | 1 |
1 trial(s) available for sulbactam and Pneumonia, Pneumococcal
Article | Year |
---|---|
Treatment of childhood complicated community-acquired pneumonia with amoxicillin/sulbactam.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Child; Child, Preschool; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Inpatients; Male; Pneumonia; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Sulbactam; Treatment Outcome | 2005 |
3 other study(ies) available for sulbactam and Pneumonia, Pneumococcal
Article | Year |
---|---|
First report on multidrug-resistant non-encapsulated Streptococcus pneumoniae isolated from a patient with pneumonia.
Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Cefozopran; Cephalosporins; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Microbial Sensitivity Tests; Myopathies, Structural, Congenital; Ophthalmoplegia; Pneumonia, Pneumococcal; Ryanodine Receptor Calcium Release Channel; Sputum; Streptococcus pneumoniae; Sulbactam | 2020 |
Outbreaks of influenza B infection and pneumococcal pneumonia at a mental health facility in Japan.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Antiviral Agents; Disease Outbreaks; Humans; Influenza B virus; Influenza, Human; Japan; Long-Term Care; Middle Aged; Pneumonia, Pneumococcal; Psychiatric Nursing; Serotyping; Streptococcus pneumoniae; Sulbactam | 2017 |
Ampicillin/sulbactam in elderly patients with community-acquired pneumonia.
Topics: Age Factors; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Community-Acquired Infections; Female; Humans; Injections, Intravenous; Male; Microbial Sensitivity Tests; Plasma; Pneumonia, Pneumococcal; Prospective Studies; Streptococcus pneumoniae; Sulbactam; Time Factors; Treatment Outcome | 2014 |